ZEPHYRTEL
ZephyrTel, a division of ESW Capital dedicated to serving global telecommunications operators, is pleased to announce that it has today signed a telecom-focused Strategic Collaboration Agreement with Amazon Web Services (AWS).
This agreement comes less than a year after ZephyrTel’s formation and is testament to the company’s growth strategy and focus on cloud leadership in the Telco market. The strategic collaboration agreement will initially be focused on a joint go-to market approach based on ZephyrTel’s industry leading Customer Experience Management platform, ResponseTek for Telco, which was the first ZephyrTel solution to be migrated to AWS.
Work is already underway to migrate other ZephyrTel solutions to AWS, including Mobilogy, OASIS Cloud Contact Centre, Volt Delta 360 Directory Assistance, PeerApp and Vasona, as well as NewNet Messaging and the Invigorate Rating and Charging platform which ZephyrTel acquired in December 2018.
ZephyrTel’s Dev Factory is also working with AWS in the Artificial Intelligence (AI) and Machine Learning (ML) space and development is underway on the first suite of predictive analytics applications built on AWS.
Mike Shinya, CEO of ZephyrTel, said, “We are dedicated to partnering with our 330 global Telco Operator customers on their journey to becoming Digital Telcos. We expect our cloud offerings to deliver Total Cost of Ownership savings to our customers of up to 90% and we are thrilled to work with AWS’s dedicated Telecom business to extend our joint offerings.”
“Telecommunication service providers are accelerating their migration to AWS in order to deliver lower total cost of IT for their organizations as well as increase automation of their services and business processes in order to drive agility and innovation for their customers,” said Jean-Philippe Poirault, Vice President and Global Head of Telecom, Amazon Web Services EMEA SARL. “We are excited to support ZephyrTel in delivering cloud-deployable telecom solutions on AWS to enable and accelerate the digital transformation journey of our shared customers.”
The agreement will also see ZephyrTel join the AWS Partner Network (APN) with immediate effect. The APN is a global partner program that helps APN Partners build successful AWS-based businesses or solutions by providing business, technical, marketing, and go-to-market support.
About ZephyrTel
Launched in early 2018, ZephyrTel has rapidly scaled up to reach $70M revenues in a short space of time. ZephyrTel has installations in over 50 countries around the world and its customers include more than 330 of the global leading Telecom Operators. The company has access to over 4000 of the world’s top talented engineers and other skilled professionals, available through affiliated company Crossover for Work’s platform. ZephyrTel is currently serving the telecommunications industry worldwide with software products for retail, infrastructure, mobile, cloud, and customer experience and is continuously extending its telco product range. More information is available at www.zephyrtel.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190402005511/en/
Contact:
ZephyrTel For further information please email: Mike Shinya, CEO mike.shinya@zephyrtel.com Ali Perkins, Chief Marketing Officer ali.perkins@zephyrtel.com
For media enquiries please email: Paula Elliott, Managing Director, C8 Consulting paula@c8consulting.co.uk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 05:25:00 CET | Press release
FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 04:31:00 CET | Press release
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig
OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 03:00:00 CET | Press release
Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl
Cessna Citation CJ3 Gen2 Enters Into Service, Delivering the Most Significant Gen2 Updates to Date8.1.2026 22:30:00 CET | Press release
The Cessna Citation CJ3 Gen2 has entered into service, setting a new standard for the Citation Gen2 family. Launch customers and longtime Citation owners Dave Mecartney and Shannon Day took delivery of their new aircraft this week. Mecartney—an experienced aviator with nearly two decades flying Citation light jets and a member of Textron Aviation’s Customer Advisory Board—helped shape the enhancements that elevate the CJ3 Gen2 experience. Key upgrades include Garmin autothrottle technology, added pilot legroom and a fully customizable cabin environment, all driven by customer feedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108455097/en/ Cessna Citation CJ3 Gen2 enters into service, delivering the most significant Gen2 updates to date (Photo credit: Textron Aviation). The Cessna Citation CJ3 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The Citation CJ3 Gen2 deliv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom